Kymera Therapeutics, Inc.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Booth Bruce

Director

—

$314.97M (216) scheduled

−$314.97M

466,077

0.5605%

$54.80M

—

BAKER BROS. ADVISORS LP entity

Director

$201.34M (5)

—

+$201.34M

7,955,916

9.57%

$935.38M

+50.3%

BVF PARTNERS L P/IL entity

Director

$84.80M (40)

$173.67M (4)

−$88.86M

318,910

0.3835%

$37.49M

—

Mainolfi Nello

Chief Executive Officer

—

$51.96M (72) scheduled

−$51.96M

666,568

0.8016%

$78.37M

+75.0%

Atlas Venture Fund X, L.P. entity

10% owner

—

$46.06M (40)

−$46.06M

5,504,905

6.62%

$647.21M

+631.6%

ATLAS VENTURE ASSOCIATES X, L.P. entity

10% owner

—

$27.73M (2)

−$27.73M

0

0.0000%

$0.00

−100.0%

Gollob Jared

Chief Medical Officer

—

$20.60M (46) scheduled

−$20.60M

117,134

0.1409%

$13.77M

+8.9%

Jacobs Bruce N.

Chief Financial Officer

—

$18.73M (41) scheduled

−$18.73M

244,883

0.2945%

$28.79M

+886.6%

Chadwick Jeremy G

Chief Operating Officer

—

$15.81M (33) scheduled

−$15.81M

44,018

0.0529%

$5.18M

+2,137%

Chesworth Richard

Chief Scientific Officer

—

$4.75M (5) scheduled

−$4.75M

0

0.0000%

$0.00

—

Esposito Pamela

Director

—

$4.07M (16) scheduled

−$4.07M

1,000

0.0012%

$117.57K

—

Goodman Noah

Chief Business Officer

—

$2.22M (9) scheduled

−$2.22M

47,179

0.0567%

$5.55M

+10,282%

Ridloff Elena

Director

—

$2.06M (7) scheduled

−$2.06M

0

0.0000%

$0.00

—

Albers Jeffrey W.

Director

—

$1.80M (8) scheduled

−$1.80M

0

0.0000%

$0.00

—

Adams Brian

Chief Legal Officer

—

$744.30K (3)

−$744.30K

50,254

0.0604%

$5.91M

—

Horobin Joanna

Director

—

$280.40K (2) scheduled

−$280.40K

0

0.0000%

$0.00

—

Chiniara Ellen

Chief Legal Officer

—

$273.30K (4)

−$273.30K

80,085

0.0963%

$9.42M

+3,914%

Caughey Elaine

Chief Business Officer

—

$22.13K (2)

−$22.13K

18,986

0.0228%

$2.23M

+786.0%

Hall Steven Edward

Director

—

2,192,249

2.64%

$257.74M

—

Redmile Group, LLC entity

10% owner

—

1,630,660

1.96%

$191.72M

—

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

10% owner

—

959,211

1.15%

$112.77M

—

Alexandria Venture Investments, LLC entity

10% owner

—

467,932

0.5628%

$55.01M

—

Rooney Terence

Chief Medical Officer

—

38,000

0.0457%

$4.47M

—

Kymera Therapeutics, Inc.

By person

Individual transactions

What was left out